GANX · CIK 0001819411 · operating
Gain Therapeutics, Inc. (GANX) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $97 million, Gain Therapeutics, Inc. is a micro-cap company. The stock currently trades at $2.70, up 3.45% today, with a 52-week range of $1.41–$4.34.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-0.89 | $-0.89 | +48.0% | |
| 2023 | $-1.71 | $-1.71 | -15.5% | |
| 2022 | $-1.48 | $-1.48 | -8.0% | |
| 2021 | $-1.37 | $-1.37 | — |